Cancer Medicines: What Is Essential and Affordable in India?

Manju Sengar Adam M Fundytus Wilma M Hopman Conjeevaram S Pramesh Venkatraman Radhakrishnan Prasanth Ganesan Aju Mathew Dorothy Chilambe Lombe Matthew Jalink Bishal GyawaliDario TrapaniFelipe Santa Rosa RoitbergElisabeth G E De VriesLorenzo Moja Gerald W Prager Richard Sullivan Christopher M Booth

Published in: JCO global oncology (2022)

Most high-priority cancer medicines identified by Indian oncologists are generic chemotherapy agents that provide substantial improvements in survival and are already included in WHO EML. Access to these treatments remains limited by major financial burdens experienced by patients. This is particularly acute within the private health system. Strategies are urgently needed to ensure that high-quality cancer care is affordable and accessible to all patients in India.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed

chronic kidney disease
prognostic factors
healthcare

young adults
squamous cell
hepatitis b virus

extracorporeal membrane oxygenation
respiratory failure